We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Westlake Corp
WLK
$9.64B
| $8.6M | 0.15% |
80,749
+73,492
| +1,013% | +$6.81M |
|
152
Edwards Lifesciences
EW
$48.3B
| $8.55M | 0.15% |
227,574
-284,379
| -56% | -$10.4M |
|
153
Pentair
PNR
$10B
| $8.51M | 0.15% |
179,438
+2,429
| +1% | +$114K |
|
|
OA
154
DELISTED
Orbital ATK, Inc.
OA
| $8.51M | 0.15% |
64,702
+58,269
| +906% | +$7.73M |
|
155
Danaher
DHR
$135B
| $8.41M | 0.15% |
102,204
-286,311
| -74% | -$23.3M |
|
156
Vornado Realty Trust
VNO
$7.34B
| $8.36M | 0.15% |
106,971
+32,494
| +44% | +$2.49M |
|
157
D.R. Horton
DHI
$39.9B
| $8.33M | 0.15% |
163,135
+136,323
| +508% | +$6.35M |
|
158
Exelixis
EXEL
$14B
| $8.3M | 0.14% |
273,002
+32,530
| +14% | +$865K |
|
|
LLL
159
DELISTED
L3 Technologies, Inc.
LLL
| $8.29M | 0.14% |
41,924
-1,250
| -3% | -$238K |
|
160
Weyerhaeuser
WY
$17B
| $8.27M | 0.14% |
234,462
+189,274
| +419% | +$6.7M |
|
161
NVR
NVR
$16.5B
| $8.22M | 0.14% |
2,343
+2,159
| +1,173% | +$7.03M |
|
162
AGCO
AGCO
$8.49B
| $8.16M | 0.14% |
114,216
+106,423
| +1,366% | +$7.59M |
|
163
Aon
AON
$76B
| $8.04M | 0.14% |
60,013
+56,654
| +1,687% | +$8.06M |
|
164
Marvell Technology
MRVL
$188B
| $7.92M | 0.14% |
368,826
+183,797
| +99% | +$3.75M |
|
|
MRO
165
DELISTED
Marathon Oil Corporation
MRO
| $7.91M | 0.14% |
466,973
-95,529
| -17% | -$1.42M |
|
166
AutoZone
AZO
$47.7B
| $7.89M | 0.14% |
11,091
-4,923
| -31% | -$3.15M |
|
167
Restaurant Brands International
QSR
$25.1B
| $7.79M | 0.14% |
+126,642
| New | +$8.12M |
|
168
Vistra
VST
$57B
| $7.74M | 0.13% |
422,382
+349,483
| +479% | +$6.55M |
|
169
Perrigo
PRGO
$1.4B
| $7.72M | 0.13% |
88,572
+82,972
| +1,482% | +$7.13M |
|
170
Huntington Ingalls Industries
HII
$11.3B
| $7.68M | 0.13% |
32,581
+2,776
| +9% | +$655K |
|
171
Lear
LEA
$7.14B
| $7.59M | 0.13% |
42,964
+17,450
| +68% | +$3.06M |
|
172
PVH
PVH
$3.59B
| $7.55M | 0.13% |
55,011
+41,864
| +318% | +$5.47M |
|
|
XEC
173
DELISTED
CIMAREX ENERGY CO
XEC
| $7.52M | 0.13% |
61,623
+41,070
| +200% | +$4.79M |
|
174
CME Group
CME
$91.9B
| $7.48M | 0.13% |
51,195
-93,210
| -65% | -$13.3M |
|
175
Everest Group
EG
$14.9B
| $7.44M | 0.13% |
33,639
-11,065
| -25% | -$2.5M |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.